Moreover, recent studies have demonstrated that CD8+ T cells remain functional despite PD-1 expression in different tumors such as breast cancer, non-small cell lung cancer, and gastric cancer (54–56). This evidence concerns the gene CD8A and non-small cell lung carcinoma.